Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial

This study has been completed.

Study NCT00061451 Information provided by Eli Lilly and Company

First Received: May 28, 2003 Last Updated: April 7, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	September 2006
Estimated Primary Completion Date:	No date given